Showing results (1791-1800 of 3,105) with videos related to

Sort By:
Pageof 311
Drug Safety|June 1, 1996
Adverse metabolic effects of antihypertensive drugs. Implications for treatmentH G Preuss, J F Burris
Drug Safety|June 1, 1996
A risk-benefit assessment of agents used in the treatment of scabiesM L Elgart
Drug Safety|April 20, 2010
Pharmacologically-induced metabolic acidosis: a reviewGeorge Liamis, Haralampos J Milionis, Moses Elisaf
Drug Safety|September 3, 2009
Pharmacovigilance of biopharmaceuticals: challenges remainThijs J Giezen, Aukje K Mantel-Teeuwisse, Hubert G M Leufkens
Drug Safety|September 3, 2009
Communicating the risk of side effects to patients: an evaluation of UK regulatory recommendationsPeter Knapp, David K Raynor, Elizabeth Woolf, et al.
Drug Safety|September 2, 2008
Drug-induced pancreatitis : incidence, management and preventionAnil R Balani, James H Grendell
Drug Safety|July 19, 2008
Safety of efalizumab therapy in patients with moderate to severe psoriasis: an open-label extension of a phase IIIb trialTiffani Hamilton, Alan Menter, Ivor Caro, et al.
Drug Safety|May 23, 2009
Treatment of chronic non-malignant pain in the elderly: safety considerationsJonathan Bruce Barber, Stephen J Gibson
Drug Safety|May 23, 2009
Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring studyRachna Kasliwal, Lynda V Wilton, Saad A W Shakir
Drug Safety|May 8, 2009
Hypoglycaemia with oral antidiabetic drugs: results from prescription-event monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinideVeronika Vlckova, Victoria Cornelius, Rachna Kasliwal, et al.
Pageof 311